We use cookies for a better user experience. Read our Privacy Policy

I Agree

Heart Valve Devices Market

Heart Valve Devices Market (Type: Mechanical Heart Valve, Biological Heart Valve, and Transcatheter Aortic Valve) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Global Heart Valve Devices Market Outlook 2031

  • The global heart valve devices market was valued at US$ 8.7 Bn in 2021
  • The global market is projected to grow at a CAGR of 11.9% from 2022 to 2031
  • The global heart valve devices market is anticipated to reach US$ 26.3 Bn by the end of 2031

Analysts’ Viewpoint on Global Heart Valve Devices Market Scenario

Developments in structural heart devices and procedures, such as aortic valve replacement valves, left arterial closure devices, and tissue or biological valves are projected to fuel the growth of the global heart valve devices market. However, increasing costs of minimally invasive procedures deter patients from undergoing surgery, which in turn hampers the growth of the global heart valve devices market. Heart valve device manufacturers should focus on the efficacy, reproducibility, versatility, and technical complexity of the product. Companies in the global heart valve devices market should focus on developing heart valves from synthetic material for improved durability, and similar mechanical function to native valves, while reducing dependency on anticoagulant and antithrombotic therapy.

heart valve device market

Overview of Global Heart Valve Devices Market

Heart valve devices are used for the treatment of a blockage in the heart valves, and implantation of these devices is one of the common procedures. Various structural heart valve equipment available in the market are mechanical heart valves, biological heart valves, and transcatheter heart valves. The global heart valve devices market is likely to grow at a steady growth rate during the forecast period, owing to an increase in heart valve surgeries across the world.

Request a Sample to get extensive insights into the Heart Valve Devices Market

Regulatory Approvals for Advanced Prosthetic Heart Valves to Propel Demand for Heart Valve Devices

The global heart valve devices market is estimated to reach US$ 9.5 Bn by 2022. When hypertension and diabetes coexist, the risk of cardiovascular disease increases. The prevalence of these disorders is rising due to socioeconomic factors such as lifestyle-induced diet, physical inactivity, and other habits such as smoking. Cardiovascular diseases are becoming more common, and regulatory approvals for new and advanced prosthetic heart valves are increasing the demand for heart valve devices.

According to the Nemours Foundation, around one in every 100 newborns has congenital heart defects, which can range from mild to severe. In addition, according to Micro Interventional Devices, Inc., structural heart defects affect about 60 million people in the U.S. or about 20% to 25% of the adult population.

Innovations in Heart Valve Devices Offer Improved Clinical Outcome

The introduction of new products for use in minimally invasive procedures is likely to propel the global heart valve devices market. Tissue valves have already revolutionized the heart valve devices market. Next-generation heart valve surgeries offer lower delivery profiles, more controlled placement, improved valve function, reduced paravalvular regurgitation, increased durability, and lower cost. Product innovation has increased the growth prospects for heart valve device market players by allowing the treatment of a larger patient population, while achieving superior clinical outcomes.

Despite significant progress in the past few years, interventional structural heart treatment is still in the nascent market with significant potential. Clever design, new technologies, and novel biomaterial applications continue to push the boundaries of new product development, ensuring that these devices are at the forefront of interventional product innovation for several years to come. Design innovations are helping market players to seize the lucrative growth opportunities in heart valve devices.

Advancements in Transcatheter Valve Technology to Boost Global Market

In terms of type, the transcatheter aortic valve segment is expected to dominate the global market during the forecast period. This can be attributed to an increase in the number of transcatheter aortic valve replacement procedures due to the high incidence of heart valve diseases, ease of implantation, increase in the number of transcatheter heart valve surgery centers, and surge in the patient population.

The transcatheter aortic valve segment is likely to witness strong growth during the forecast period. Several government corporations' actions to increase knowledge about heart valve replacement surgeries are projected to drive the segment. An increase in demand for minimally invasive procedures has encouraged players to invest in the research & development of novel surgical processes. Transcatheter heart valve prosthesis product launches, such as the SAPIEN Transcatheter Heart Valve, Magna Ease Aortic and Mitral Valves, and PERIMOUNT Aortic/Mitral Valves, are anticipated to propel the demand for transcatheter valves.

Request a custom report on Heart Valve Devices Market

Regional Outlook of Global Heart Valve Devices Market

North America held the largest share of 44% of the global market in terms of volume in 2021. The region leads the global heart valve devices market in terms of the adoption of technologically superior products and techniques, as well as comparatively higher average selling prices of heart valve devices in the region.

The Asia Pacific was the second largest market for heart valve devices in 2021. The global market for heart valve devices is driven by the factors such as an increase in the geriatric population, favorable reimbursement scenarios, a rise in regulatory approvals, and the presence of a large target patient population. In addition, the surge in healthcare expenditure, implementation of government-funded insurance schemes, and growing medical tourism industry in several countries are attributable to the market growth in the Asia Pacific.

Aortic stenosis affects millions of people in Europe. These statistics highlight the need for structural heart disease treatment devices, providing impetus to develop new techniques for heart defect replacement and repair.

Analysis of Key Players in Global Heart Valve Devices Market

The global heart valve devices market is consolidated, with a small number of large players accounting for the majority of the market share. Several companies are making a significant investment in research & development primarily to develop environmentally friendly products.

Diversification of product portfolio and mergers & acquisitions are the key strategies adopted by the leading players. Some of the key market players operating in the global heart valve devices market are Abbott, Boston Scientific Corporation, CryoLife, Inc., Edward Lifesciences Corporation, JenaValve Technology, Inc., Medtronic, Inc., SYMETIS., Neovasc, Inc., Sorin Group (LivaNova plc), Micro Interventional Devices, Inc., XELTIS, TTK HealthCare, and Lepu Medical, among others.

Each of these players has been profiled in the heart valve devices market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Key Developments in Global Heart Valve Devices Market

  • In September 2021, Abbott announced the U.S. Food and Drug Administration (FDA) approval for Epic Plus and Epic Plus Supra Stented Tissue Valves to improve therapy options for people with aortic or mitral valve disease. These next-generation devices are built off Abbott's Epic surgical valve platform.
  • In September 2020, Boston Scientific launched a new aortic valve system. This transcatheter aortic valve implantation (TAVI) is a new heart valve technology designed with many features to improve the older clinical performance of the Acurate neo platform.

Global Heart Valve Devices Market Snapshot

Attribute

Detail

Market Size Value in 2021

US$ 8.7 Bn

Market Forecast Value in 2031

US$ 26.3 Bn

Growth Rate(CAGR)

11.9%

Forecast Period

2022–2031

Historical Data Available for

2017–2020

Quantitative Units

US$ Bn for Value & Tons for Volume

Market Analysis

It includes cross segment analysis at global as well as regional level. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.

Competition Landscape

  • Market share analysis by company (2021)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • Type
    • Mechanical Heart Valve
    • Biological Heart Valve
    • Transcatheter Aortic Valve
  • Distribution Channel
    • Hospitals
    • Ambulatory Surgical Centers
    • Others (Cardiac Centers, Research Centers, etc.)

Regions Covered

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Russia & CIS
  • Japan
  • China
  • India
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • Abbott
  • Boston Scientific Corporation
  • CryoLife, Inc.
  • Edward Lifesciences Corporation
  • JenaValve Technology, Inc.
  • Medtronic
  • SYMETIS
  • Neovasc, Inc.
  • Sorin Group (LivaNova plc)
  • Micro Interventional Devices, Inc.
  • XELTIS
  • TTK HealthCare
  • Lepu Medical technology
  • Other prominent players

Customization Scope

Available upon request

Pricing

Available upon request

Heart Valve Devices Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total size of the global heart valve devices market?

The global heart valve devices market was valued at US$ 8.7 Mn in 2021 and projected to reach US$ 26.3 Mn by 2031.

What is the anticipated CAGR of the global heart valve devices market?

The global heart valve devices market is expected to grow at a CAGR of 11.9% during the forecast period.

What are the major drivers of the global heart valve devices market?

Rise in prevalence of heart valve diseases and launch of innovative products are likely to boost the growth of the global market during the forecast period.

Which regional market is set to grow at the fastest CAGR during the forecast period?

The market in North America is projected to expand at the fastest CAGR from 2022 to 2031.

Which segment is anticipated to account for the largest share of the global heart valve devices market?

The transcatheter aortic valve segment is expected to account for the largest share of the global market in terms of revenue by 2031.

Who are the key players operating in the global market?

Abbott, Boston Scientific Corporation, CryoLife, Inc., Edward Lifesciences Corporation, and Medtronic, Inc. are the prominent players in the global heart valve devices market.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Heart Valve Devices Market

4. Market Overview

    4.1. Introduction

        4.1.1. Type Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Heart Valve Devices Market Analysis and Forecast, 2017–2031

5. Key Insights

    5.1. Key Mergers & Acquisitions

    5.2. Technological Advancements

    5.3. Key Mergers & Acquisitions

6. Global Heart Valve Devices Market Analysis and Forecast, by Type

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Type, 2017–2031

        6.3.1. Mechanical Heart Valve

        6.3.2. Biological Heart Valve

        6.3.3. Transcatheter Aortic Valve

    6.4. Market Attractiveness Analysis, by Type

7. Global Heart Valve Devices Market Analysis and Forecast, by Distribution Channel

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by Distribution Channel, 2017–2031

        7.3.1. Hospitals

        7.3.2. Ambulatory Surgical Centers

        7.3.3. Others (cardiac centers, research centers, etc.)

    7.4. Market Attractiveness Analysis, by Distribution Channel

8. Global Heart Valve Devices Market Analysis and Forecast, by Region

    8.1. Key Findings

    8.2. Market Value Forecast, by Region

        8.2.1. North America

        8.2.2. Europe

        8.2.3. Asia Pacific

        8.2.4. Latin America

        8.2.5. Middle East & Africa

    8.3. Market Attractiveness Analysis, by Region

9. North America Heart Valve Devices Market Analysis and Forecast

    9.1. Introduction

        9.1.1. Key Findings

    9.2. Market Value Forecast, by Type, 2017–2031

        9.2.1. Mechanical Heart Valve

        9.2.2. Biological Heart Valve

        9.2.3. Transcatheter Aortic Valve

    9.3. Market Value Forecast, by Distribution Channel, 2017–2031

        9.3.1. Hospitals

        9.3.2. Ambulatory Surgical Centers

        9.3.3. Others (cardiac centers, research centers, etc.)

    9.4. Market Value Forecast, by Country, 2017–2031

        9.4.1. U.S.

        9.4.2. Canada

    9.5. Market Attractiveness Analysis

        9.5.1. By Type

        9.5.2. By Distribution Channel

        9.5.3. By Country

10. Europe Heart Valve Devices Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast, by Type, 2017–2031

        10.2.1. Mechanical Heart Valve

        10.2.2. Biological Heart Valve

        10.2.3. Transcatheter Aortic Valve

    10.3. Market Value Forecast, by Distribution Channel, 2017–2031

        10.3.1. Hospitals

        10.3.2. Ambulatory Surgical Centers

        10.3.3. Others (cardiac centers, research centers, etc.)

    10.4. Market Value Forecast, by Country/Sub-region, 2017–2031

        10.4.1. Germany

        10.4.2. U.K.

        10.4.3. France

        10.4.4. Italy

        10.4.5. Spain

        10.4.6. Rest of Europe

    10.5. Market Attractiveness Analysis

        10.5.1. By Type

        10.5.2. By Distribution Channel

        10.5.3. By Country/Sub-region

11. Asia Pacific Heart Valve Devices Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Type, 2017–2031

        11.2.1. Mechanical Heart Valve

        11.2.2. Biological Heart Valve

        11.2.3. Transcatheter Aortic Valve

    11.3. Market Value Forecast, by Distribution Channel, 2017–2031

        11.3.1. Hospitals

        11.3.2. Ambulatory Surgical Centers

        11.3.3. Others (cardiac centers, research centers, etc.)

    11.4. Market Value Forecast, by Country/Sub-region, 2017–2031

        11.4.1. China

        11.4.2. Japan

        11.4.3. India

        11.4.4. Australia & New Zealand

        11.4.5. Rest of Asia Pacific

    11.5. Market Attractiveness Analysis

        11.5.1. By Type

        11.5.2. By Distribution Channel

        11.5.3. By Country/Sub-region

12. Latin America Heart Valve Devices Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Type, 2017–2031

        12.2.1. Mechanical Heart Valve

        12.2.2. Biological Heart Valve

        12.2.3. Transcatheter Aortic Valve

    12.3. Market Value Forecast, by Distribution Channel, 2017–2031

        12.3.1. Hospitals

        12.3.2. Ambulatory Surgical Centers

        12.3.3. Others (cardiac centers, research centers, etc.)

    12.4. Market Value Forecast, by Country/Sub-region, 2017–2031

        12.4.1. Brazil

        12.4.2. Mexico

        12.4.3. Rest of Latin America

    12.5. Market Attractiveness Analysis

        12.5.1. By Type

        12.5.2. By Distribution Channel

        12.5.3. By Country/Sub-region

13. Middle East & Africa Heart Valve Devices Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Type, 2017–2031

        13.2.1. Mechanical Heart Valve

        13.2.2. Biological Heart Valve

        13.2.3. Transcatheter Aortic Valve

    13.3. Market Value Forecast, by Distribution Channel, 2017–2031

        13.3.1. Hospitals

        13.3.2. Ambulatory Surgical Centers

        13.3.3. Others (cardiac centers, research centers, etc.)

    13.4. Market Value Forecast, by Country/Sub-region, 2017–2031

        13.4.1. GCC Countries

        13.4.2. South Africa

        13.4.3. Rest of Middle East & Africa

    13.5. Market Attractiveness Analysis

        13.5.1. By Type

        13.5.2. By Distribution Channel

        13.5.3. By Country/Sub-region

14. Competition Landscape

    14.1. Market Player - Competition Matrix (by tier and size of companies)

    14.2. Market Share Analysis, by Company, 2021

    14.3. Company Profiles

        14.3.1. Abbott

            14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.1.2. Product Portfolio

            14.3.1.3. SWOT Analysis

            14.3.1.4. Strategic Overview

        14.3.2. Boston Scientific Corporation

            14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.2.2. Product Portfolio

            14.3.2.3. SWOT Analysis

            14.3.2.4. Strategic Overview

        14.3.3. CryoLife, Inc.

            14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.3.2. Product Portfolio

            14.3.3.3. SWOT Analysis

            14.3.3.4. Strategic Overview

        14.3.4. Edward Lifesciences Corporation

            14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.4.2. Product Portfolio

            14.3.4.3. SWOT Analysis

            14.3.4.4. Strategic Overview

        14.3.5. JenaValve Technology, Inc.

            14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.5.2. Product Portfolio

            14.3.5.3. SWOT Analysis

            14.3.5.4. Strategic Overview

        14.3.6. Medtronic.

            14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.6.2. Product Portfolio

            14.3.6.3. SWOT Analysis

            14.3.6.4. Strategic Overview

        14.3.7. SYMETIS

            14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.7.2. Product Portfolio

            14.3.7.3. SWOT Analysis

            14.3.7.4. Strategic Overview

        14.3.8. Neovasc, Inc.

            14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.8.2. Product Portfolio

            14.3.8.3. SWOT Analysis

            14.3.8.4. Strategic Overview

        14.3.9. Sorin Group (LivaNova plc)

            14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.9.2. Product Portfolio

            14.3.9.3. SWOT Analysis

            14.3.9.4. Strategic Overview

        14.3.10. Micro Interventional Devices, Inc.

            14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.10.2. Product Portfolio

            14.3.10.3. SWOT Analysis

            14.3.10.4. Strategic Overview

        14.3.11. XELTIS

            14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.11.2. Product Portfolio

            14.3.11.3. SWOT Analysis

            14.3.11.4. Strategic Overview

        14.3.12. TTK HealthCare

            14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.12.2. Product Portfolio

            14.3.12.3. SWOT Analysis

            14.3.12.4. Strategic Overview

        14.3.13. Lepu Medical technology

            14.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.13.2. Product Portfolio

            14.3.13.3. SWOT Analysis

            14.3.13.4. Strategic Overview

List of Tables

Table 01: Global Heart Valve Devices Market Size (US$ Bn) Forecast, by Type, 2022–2031

Table 02: Global Heart Valve Devices Market Size (US$ Bn) Forecast, by Distribution Channel, 2022–2031

Table 03: Global Heart Valve Devices Market Size (US$ Bn) Forecast, by Region, 2022–2031

Table 04: North America Heart Valve Devices Market Size (US$ Bn) Forecast, by Country, 2022–2031

Table 05: North America Heart Valve Devices Market Size (US$ Bn) Forecast, by Type, 2022–2031

Table 06: North America Heart Valve Devices Market Size (US$) Forecast, by Distribution Channel, 2022–2031

Table 07: Europe Heart Valve Devices Market Size (US$ Bn) Forecast, by Country/Sub-region, 2022–2031

Table 08: Europe Heart Valve Devices Market Size (US$) Forecast, by Type, 2022–2031

Table 09: Europe Heart Valve Devices Market Size (US$ Bn) Forecast, by Distribution Channel, 2022–2031

Table 10: Asia Pacific Heart Valve Devices Market Size (US$ Bn) Forecast, by Country/Sub-region, 2022–2031

Table 11: Asia Pacific Heart Valve Devices Market Size (US$) Forecast, by Type, 2022–2031

Table 12: Asia Pacific Heart Valve Devices Market Size (US$ Bn) Forecast, by Distribution Channel, 2022–2031

Table 13: Latin America Heart Valve Devices Market Size (US$ Bn) Forecast, by Country/Sub-region, 2022–2031

Table 14: Latin America Heart Valve Devices Market Size (US$) Forecast, by Type, 2022–2031

Table 15: Latin America Heart Valve Devices Market Size (US$ Bn) Forecast, by Distribution Channel, 2022–2031

Table 16: Middle East & Africa Heart Valve Devices Market Size (US$ Bn) Forecast, by Country/Sub-region, 2022–2031

Table 17: Middle East & Africa Heart Valve Devices Market Size (US$) Forecast, by Type, 2022–2031

Table 18: Middle East & Africa Heart Valve Devices Market Size (US$ Bn) Forecast, by Distribution Channel, 2022–2031

List of Figures

Figure 01: Global Heart Valve Devices Market Value (US$ Bn), by Type, 2022–2031

Figure 02: Global Heart Valve Devices Market Value (US$ Bn), by Distribution Channel, 2022–2031

Figure 03: Global Heart Valve Devices Market Value (US$ Bn), by Region, 2022–2031

Figure 04: Global Heart Valve Devices Market Value Share Analysis, by Type, 2022 and 2031

Figure 05: Global Mechanical Heart Valve Market Revenue (US$ Bn) and Y-o-Y Growth (%) Forecast, 2017–2025

Figure 06: Global Biological Heart Valve Market Revenue (US$ Bn) and Y-o-Y Growth (%) Forecast, 2017–2025

Figure 07: Global Transcatheter Aortic Valve Market Revenue (US$ Bn) and Y-o-Y Growth (%) Forecast, 2017–2025

Figure 08: Global Heart Valve Devices Market Attractiveness Analysis, by Type, 2022–2031

Figure 09: Global Heart Valve Devices Market Value Share Analysis, by Distribution Channel, 2022 and 2031

Figure 10: Global Hospitals Heart Valve Devices Market Value (US$ Bn) and Y-o-Y Growth (%), 2017–2025

Figure 11: Global Ambulatory Surgical Centers Heart Valve Devices Market Value (US$ Bn) and Y-o-Y Growth (%), 2017-2025

Figure 12: Global Others (cardiac centers, research centers, etc.) Heart Valve Devices Market Value (US$ Bn) and Y-o-Y Growth (%), 2017–2025

Figure 13: Global Heart Valve Devices Market Attractiveness Analysis, by Distribution-Channel, 2022–2031

Figure 14: North America Heart Valve Devices Market Size (US$ Bn) Forecast, 2022–2031

Figure 15: Europe Heart Valve Devices Market Size (US$ Bn) Forecast, 2022–2031

Figure 16: Asia Pacific Heart Valve Devices Market Size (US$ Bn) Forecast, 2022–2031

Figure 17: Latin America Heart Valve Devices Market Size (US$ Bn) Forecast, 2022–2031

Figure 18: MEA Heart Valve Devices Market Size (US$ Bn) Forecast, 2022–2031

Figure 19: Global Heart Valve Devices Market Attractiveness Analysis, by Region, 2022–2031

Figure 20: U.S. Heart Valve Devices Market Size (US$ Bn) Forecast, 2022–2031

Figure 21: Canada Heart Valve Devices Market Size (US$ Bn) Forecast, 2022–2031

Figure 22: North America Heart Valve Devices Market Attractiveness Analysis, by Country, 2022–2031

Figure 23: North America Heart Valve Devices Market Attractiveness Analysis, by Type, 2022–2031

Figure 24: North America Heart Valve Devices Market Attractiveness Analysis, by Distribution Channel, 2022–2031

Figure 25: Germany Heart Valve Devices Market Size (US$ Bn) Forecast, 2022–2031

Figure 26: France Heart Valve Devices Market Size (US$ Bn) Forecast, 2022–2031

Figure 27: U.K. Heart Valve Devices Market Size (US$ Bn) Forecast, 2022–2031

Figure 28: Italy Heart Valve Devices Market Size (US$ Bn) Forecast, 2022–2031

Figure 29: Spain Heart Valve Devices Market Size (US$ Bn) Forecast, 2022–2031

Figure 30: Rest of Europe Heart Valve Devices Market Size (US$ Bn) Forecast, 2022–2031

Figure 31: Europe Heart Valve Devices Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 32: Europe Heart Valve Devices Market Attractiveness Analysis, by Type, 2022–2031

Figure 33: Europe Heart Valve Devices Market Attractiveness Analysis, by Distribution Channel, 2022–2031

Figure 34: China Heart Valve Devices Market Size (US$ Bn) Forecast, 2022–2031

Figure 35: Japan Heart Valve Devices Market Size (US$ Bn) Forecast, 2022–2031

Figure 36: India Heart Valve Devices Market Size (US$ Bn) Forecast, 2022–2031

Figure 37: Rest of Asia Pacific Heart Valve Devices Market Size (US$ Bn) Forecast, 2022–2031

Figure 38: Asia Pacific Heart Valve Devices Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 39: Asia Pacific Heart Valve Devices Market Attractiveness Analysis, by Type, 2022–2031

Figure 40: Asia Pacific Heart Valve Devices Market Attractiveness Analysis, by Distribution Channel, 2022–2031

Figure 41: Brazil Heart Valve Devices Market Size (US$ Bn) Forecast, 2022–2031

Figure 42: Mexico Heart Valve Devices Market Size (US$ Bn) Forecast, 2022–2031

Figure 43: Rest of Latin America Heart Valve Devices Market Size (US$ Bn) Forecast, 2022–2031

Figure 44: Latin America Heart Valve Devices Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 45: Latin America Heart Valve Devices Market Attractiveness Analysis, by Type, 2022–2031

Figure 46: Latin America Heart Valve Devices Market Attractiveness Analysis, by Distribution Channel, 2022–2031

Figure 47: South Africa Heart Valve Devices Market Size (US$ Bn) Forecast, 2022–2031

Figure 48: Saudi Arabia Heart Valve Devices Market Size (US$ Bn) Forecast, 2022–2031

Figure 49: Rest of MEA Heart Valve Devices Market Size (US$ Bn) Forecast, 2022–2031

Figure 50: Middle East & Africa Heart Valve Devices Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 51: Middle East & Africa Heart Valve Devices Market Attractiveness Analysis, by Type, 2022–2031

Figure 52: Middle East & Africa Heart Valve Devices Market Attractiveness Analysis, by Distribution Channel, 2022–2031

Figure 53: Heart Valve Devices Market Share Analysis by Company 2022–2031

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

500

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved